Myriad Genetics, Inc.

DB:MYD Stock Report

Market Cap: €1.3b

Myriad Genetics Future Growth

Future criteria checks 1/6

Myriad Genetics is forecast to grow earnings and revenue by 60.5% and 7.2% per annum respectively. EPS is expected to grow by 61.4% per annum. Return on equity is forecast to be 4.4% in 3 years.

Key information

60.5%

Earnings growth rate

61.4%

EPS growth rate

Biotechs earnings growth43.0%
Revenue growth rate7.2%
Future return on equity4.4%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:MYD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026975-12244810
12/31/2025888-6593314
12/31/2024841-1043614
9/30/2024824-116-107-70N/A
6/30/2024802-155-141-93N/A
3/31/2024774-235-155-96N/A
12/31/2023753-263-184-111N/A
9/30/2023734-274-138-63N/A
6/30/2023699-248-119-44N/A
3/31/2023695-146-155-93N/A
12/31/2022678-112-152-106N/A
9/30/2022661-77-143-108N/A
6/30/2022672-18-164-145N/A
3/31/2022682-8-117-100N/A
12/31/2021691-27119N/A
9/30/2021684-57-714N/A
6/30/2021662-97-26-6N/A
3/31/2021566-1481128N/A
12/31/2020557-224-40-27N/A
9/30/2020598-194-25-14N/A
6/30/2020639-1995161N/A
3/31/2020761-1485362N/A
12/31/2019813-264352N/A
9/30/2019835-158392N/A
6/30/201985157584N/A
3/31/20198302391100N/A
12/31/20187962696105N/A
9/30/20187675492100N/A
6/30/2018744133N/A116N/A
3/31/2018749130N/A105N/A
12/31/2017763126N/A134N/A
9/30/2017771101N/A133N/A
6/30/201772917N/A106N/A
3/31/201775732N/A108N/A
12/31/201675163N/A113N/A
9/30/201674894N/A134N/A
6/30/2016741117N/A166N/A
3/31/2016757121N/A179N/A
12/31/2015747108N/A163N/A
9/30/201573895N/A163N/A
6/30/201572380N/A141N/A
3/31/201572295N/A130N/A
12/31/2014725110N/A112N/A
9/30/2014745137N/A107N/A
6/30/2014778176N/A190N/A
3/31/2014764187N/A212N/A
12/31/2013737188N/A238N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MYD is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MYD is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MYD is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MYD's revenue (7.2% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: MYD's revenue (7.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MYD's Return on Equity is forecast to be low in 3 years time (4.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y